BMA Stock Analysis: Banco Macro | NYSE
Banks - Regional | NYSE, USA | Market Cap: 5.770m USD | 12M Return: 48.5% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 24.7M
Qual. Beats: 0
Rev. Trend: -1.8%
Qual. Beats: 0
Warnings
Tailwinds
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Banco Macro S.A. is an Argentine commercial bank operating a universal banking model that spans retail and corporate clients. Founded in 1966 and headquartered in Buenos Aires, the company offers deposit products (savings, checking, and time deposits), consumer and mortgage loans, credit and debit cards, insurance distribution, ATMs, tax collection, utility payments, and money transfer services. For retail customers, the bank also extends personal loans, document discounts, residential mortgages, pledged loans, and overdraft facilities.
On the corporate side, Banco Macro provides deposits, lending, factoring, guaranteed loans, foreign trade credit lines, cash management, trust and payroll services, leasing, and working capital and investment project financing, along with transaction services such as collections, supplier payments, foreign exchange, and internet and mobile banking. As a GICS-classified Diversified Bank trading on the NYSE via an ADR (ticker BMA, listed since March 2006), it sits within the financials sector and is exposed to Argentine macroeconomic conditions, where high inflation and peso volatility have historically shaped bank net interest margins and loan demand.
- Argentina inflation surge drives deposit growth and fee income
- BCRA interest rate cuts compress net interest margins
- Peso depreciation pressures dollar-denominated ADR returns
| Net Income: 256b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.00 > 0.02 and ΔFCF/TA -3.18 > 1.0 |
| NWC/Revenue: -232.6% < 20% (prev -145.4%; Δ -87.22% < -1%) |
| CFO/TA -0.00 > 3% & CFO -47.7b > Net Income 256b |
| Net Debt (-3225b) to EBITDA (143b): -22.62 < 3 |
| Current Ratio: 0.32 > 1.5 & < 3 |
| Outstanding Shares: last quarter (63.9m) vs 12m ago -0.00% < -2% |
| Gross Margin: 59.58% > 18% (prev 54.82%; Δ 4.76% > 0.5%) |
| Asset Turnover: 23.60% > 50% (prev 28.12%; Δ -4.51% > 0%) |
| Interest Coverage Ratio: 0.09 > 6 (EBIT TTM 133b / Interest Expense TTM 1424b) |
| A: -0.46 (Total Current Assets 5189b - Total Current Liabilities 16262b) / Total Assets 24200b |
| B: 0.02 (Retained Earnings 458b / Total Assets 24200b) |
| C: 0.01 (EBIT TTM 133b / Avg Total Assets 20172b) |
| D: 0.32 (Book Value of Equity 5856b / Total Liabilities 18342b) |
| Altman-Z'' = -2.56 = D |
| DSRI: 0.77 (Receivables 401b/499b, Revenue 4761b/4539b) |
| GMI: 0.92 (GM 54.82% / 59.58%) |
| AQI: 0.98 (AQ_t 0.74 / AQ_t-1 0.75) |
| SGI: 1.05 (Revenue 4761b / 4539b) |
| TATA: 0.01 (NI 256b - CFO -47.7b) / TA 24200b) |
| Beneish M = -3.27 (Cap -4..+1) = AA |
As of July 08, 2026, the stock is trading at USD 91.65 with a total of 145,255 shares traded. Over the past week, the price has changed by -0.33%, over one month by +9.87%, over three months by +24.44% and over the past year by +48.50%.
Current recommended Stop Loss: 86.10 (which is 6.1% or 1.2 ATR below the current price).
Banco Macro has received a consensus analysts rating of 3.86. Therefore, it is recommended to buy BMA.
- StrongBuy: 2
- Buy: 2
- Hold: 3
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 113.4 | 23.8% |
P/E Trailing = 23.0204
P/E Forward = 3.0979
P/S = 0.0018
P/B = 1.4564
P/EG = 0.4681
Revenue TTM = 4761b USD
EBIT TTM = 133b USD
EBITDA TTM = 143b USD
Long Term Debt = 1465b USD (from longTermDebt, last quarter)
Short Term Debt = 225.5m USD (from shortTermDebt, last quarter)
Debt = 1497b USD (from shortLongTermDebtTotal, last quarter) + Leases 15.9b
Net Debt = -3225b USD (calculated: Debt 1497b - CCE 4721b)
Enterprise Value = 5.77b USD (floored to Market Cap, CCE > MCap+Debt)
Interest Coverage Ratio = 0.09 (Ebit TTM 133b / Interest Expense TTM 1424b)
EV/FCF = 3.69x (Enterprise Value 5.77b / FCF TTM 1.56b)
FCF Yield = 27.11% (FCF TTM 1.56b / Enterprise Value 5.77b)
FCF Margin = 0.03% (FCF TTM 1.56b / Revenue TTM 4761b)
Net Margin = 5.38% (Net Income TTM 256b / Revenue TTM 4761b)
Gross Margin = 59.58% ((Revenue TTM 4761b - Cost of Revenue TTM 1924b) / Revenue TTM)
Gross Margin QoQ = 61.12% (prev 51.25%)
Tobins Q-Ratio = 0.00 (Enterprise Value 5.77b / Total Assets 24200b)
Interest Expense / Debt = 95.13% (Interest Expense 1424b / Debt 1497b)
Taxrate = 9.19% (38.6b / 420b)
NOPAT = 121b (EBIT 133b * (1 - 9.19%))
Current Ratio = 0.32 (Total Current Assets 5189b / Total Current Liabilities 16262b)
Debt / Equity = 0.26 (Debt 1497b / totalStockholderEquity, last quarter 5856b)
Debt / EBITDA = -22.62 (Net Debt -3225b / EBITDA 143b)
Debt / FCF = -2.06k (out of range, set to none) (Net Debt -3225b / FCF TTM 1.56b)
Total Stockholder Equity = 4684b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.27% (Net Income 256b / Total Assets 24200b)
RoE = 5.47% (Net Income TTM 256b / Total Stockholder Equity 4684b)
RoCE = 2.16% (EBIT 133b / Capital Employed (Equity 4684b + L.T.Debt 1465b))
RoIC = 1.57% (NOPAT 121b / Invested Capital 7700b)
WACC = 0.04% (E(5.77b)/V(1502b) * Re(9.25%) + (debt cost/tax rate unavailable))
Discount Rate = 9.25% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 20.45 | Cagr: 0.01%
[DCF] Terminal Value 73.10% ; FCFF base≈207b ; Y1≈181b ; Y5≈146b
[DCF] Fair Price = 88.8k (EV 2351b - Net Debt -3225b = Equity 5575b / Shares 62.8m; r=8.35% [WACC [floored]]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 0.41 | # QB: 0
Revenue Correlation: -1.78 | Revenue CAGR: -0.69% | SUE: 0.68 | # QB: 0
EPS current Quarter (2026-06-30): EPS=2191.02 | Chg30d=+34.27% | Revisions=+40% | Analysts=3
EPS next Quarter (2026-09-30): EPS=2575.39 | Chg30d=+50.37% | Revisions=+40% | Analysts=3
EPS current Year (2026-12-31): EPS=9626.07 | Chg30d=+11.92% | Revisions=+0% | GrowthEPS=+76.8% | GrowthRev=+49.5%
EPS next Year (2027-12-31): EPS=14635.91 | Chg30d=+7.56% | Revisions=+50% | GrowthEPS=+52.0% | GrowthRev=+14.5%
[Analyst] Revisions Ratio: +58% (up=8, down=1)